No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
RVNC250117P4000
- 0.00
- 0.000.00%
15min DelayClose Jan 10 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest4.00Strike Price0.00Turnover0.00%IV-23.08%PremiumJan 17, 2025Expiry Date0.75Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
Express News | Crown Laboratories Extension of Tender Offer to Acquire Revance Therapeutics, Inc.
Press Release: Crown Laboratories Extension of Tender Offer to Acquire Revance Therapeutics, Inc.
Key Deals This Week: FuboTV - Disney, Constellation Energy, Eli Lilly, Phillips 66, Intercontinental Exchange and More
Mizuho Securities Maintains Revance Therapeutics(RVNC.US) With Hold Rating
Sector Update: Health Care Stocks Rise in Afternoon Trading
Sector Update: Health Care